What are the Applications of Mangosteen Extract in Oral Health?
May 07, 2026
The global oral care market is undergoing a significant transformation. Consumers are increasingly seeking natural, effective alternatives to synthetic antimicrobial agents traditionally used in mouthwashes, toothpastes, and dental gels. Conventional ingredients such as chlorhexidine and cetylpyridinium chloride, while effective, come with well-documented drawbacks: tooth staining, taste alteration, mucosal irritation, and disruption of the beneficial oral microbiome. Enter α-mangostin, the primary bioactive xanthone derived from the pericarp of mangosteen (Garcinia mangostana L.). This natural compound has become a promising option for oral care. It has a distinctive blend of antimicrobial, anti-inflammatory, and antibiofilm effects with minimal cytotoxicity. This article explores how Mangosteen Extract Powder (standardised to α-mangostin) can be a primary active ingredient in advanced oral care products, including toothpastes, mouthwashes, oral sprays, and dental gels.
What is Mangostin?
α-Mangostin is a type of xanthone that belongs to a group of polyphenolic compounds recognised for their diverse biological activities. It is the primary and most active bioactive compound in the mangosteen pericarp, usually making up 5-20% of the dried rind by weight. For use in oral care products, Mangosteen Extract can be standardised to contain different levels of α-mangostin (10%, 40%, or 90% and above), enabling manufacturers to choose the suitable purity level according to the product's needs and budget.
What are its mechanisms of action in oral care?
Research has identified three primary mechanisms through which α-mangostin exerts its oral health benefits:
A. Direct Antimicrobial Activity
α-Mangostin demonstrates potent activity against key oral pathogens, including:
a. Streptococcus mutans (primary cause of dental caries)
b. Porphyromonas gingivalis (keystone pathogen in periodontitis)
c. Candida albicans (the most common cause of oral fungal infections)
Studies have established minimum inhibitory concentration (MIC) values of 117 µg/mL for α-mangostin against all three pathogens, with minimum bactericidal/fungicidal concentrations (MBC/MFC) of 234 µg/mL. Time-kill assays show that α-mangostin reduces microbial growth by 1-3 Log CFU/mL within 2-4 hours, achieving complete killing at 24 hours.
B. Antibiofilm Formation
The ability of oral pathogens to develop biofilms (dense, protective bacterial communities) poses a primary challenge in managing dental plaque, caries, and periodontitis. Conventional antimicrobials often fail to penetrate these biofilms effectively. α-Mangostin has demonstrated significant antibiofilm activity against S. mutans, P. gingivalis, and C. albicans. Importantly, it inhibits biofilm formation without the cytotoxicity associated with synthetic agents.
C. Anti-Inflammatory Effects
Periodontal disease is fundamentally an inflammatory condition. α-Mangostin exhibits dose-dependent anti-inflammatory activity by inhibiting nitric oxide (NO) production in macrophages. This anti-inflammatory effect complements its antimicrobial action, addressing both the infectious and inflammatory components of periodontal disease.
What clinical evidence supports the efficacy of mangostin in oral care?
Chronic Catarrhal Gingivitis
A clinical study published in the Kazan Medical Journal (2020) evaluated a dental hygiene gel containing 1% α-mangostin in patients with chronic generalised catarrhal gingivitis. Key findings:
a. 100% elimination of gum bleeding, pain, and bad breath in the α-mangostin group
b. 85% reduction in the PMA index (inflammatory severity) vs. 51% for the metronidazole/chlorhexidine group
c. 79% reduction in OHI-S (oral hygiene index) vs. no significant improvement in the control group
The authors concluded that α-mangostin-based gel demonstrated superior clinical outcomes compared to both standard treatment and combination therapy containing 1% metronidazole + 0.25% chlorhexidine.
Soluble Film Formulation
A 2022 study developed a mucoadhesive soluble film containing α-mangostin (7.3% loading). The film demonstrated:
a. Stable pH (6.3) suitable for oral application
b. Complete killing of S. mutans, P. gingivalis, and C. albicans within 24 hours
c. No cytotoxicity at therapeutic doses (≤29.2 µg/mL)
d. Dose-dependent anti-inflammatory activity
The film's mucoadhesive properties, enhanced by hydroxypropyl methylcellulose (HPMC), provide prolonged contact time with oral tissues, maximising therapeutic benefit.
Synergistic Formulations
Research has shown that α-mangostin works synergistically with other plant-derived compounds. An oral spray containing both α-mangostin (2.5 mg/mL) and lawsone methyl ether (LME, 125 µg/mL) demonstrated:
a. Greater antimicrobial activity than either compound alone
b. Enhanced biofilm inhibition
c. Superior anti-inflammatory effects compared to α-mangostin alone
Similarly, a tooth gel combining α-mangostin with lawsone methyl ether and fluoride showed synergistic antimicrobial effects and increased enamel microhardness.
What are the applications of mangostin in oral care products?
1. Oral Care Product Formats
Mangosteen extract can be added to various oral care products, each providing distinct benefits and requiring specific formulation considerations.
A. Toothpaste / Gel
a. Key Benefits: Daily caries prevention and anti-inflammatory action
b. Considerations: Requires a compatible base formulation; pH should be maintained between 5.0-7.0 for stability
B. Mouthwash
a. Key Benefits: Broad antimicrobial coverage and biofilm disruption
b. Considerations: Solubility challenge due to α-mangostin's poor water solubility; requires nano-emulsification or other advanced dispersion technologies
C. Oral Spray
a. Key Benefits: On-the-go application with rapid action
b. Considerations: Proven effective in clinical studies when combined with synergistic compounds such as lawsone methyl ether
D. Mucoadhesive Film / Patch
a. Key Benefits: Targeted delivery with prolonged release at the application site
b. Considerations: Ideal for localised periodontal treatment and recurrent aphthous stomatitis (canker sores); provides a protective barrier against saliva wash-out
E. Chewing Gum
a. Key Benefits: Saliva stimulation and sustained release during chewing
b. Considerations: Suitable for low-dose daily use; ensures prolonged oral exposure time
2. Formulation Considerations
A. Solubility Challenge: α-Mangostin is practically insoluble in water (0.1-0.5 mg/mL). For aqueous oral care products (mouthwashes, sprays), formulators should consider:
a. Nano-emulsification to improve dispersion
b. Liposomal encapsulation for enhanced bioavailability
c. Use of solubilisers such as PEG-40 hydrogenated castor oil
d. Non-aqueous formulations (gels, films, pastes)
B. Stability: α-Mangostin is heat-sensitive and susceptible to oxidative degradation. Formulations should:
a. Avoid high-temperature processing
b. Include antioxidants (e.g., vitamin E, rosemary extract)
c. Use opaque or amber packaging
d. Maintain pH between 5.0 and 7.0
What other plant-derived active ingredients can be used in oral care products?
Comparison with Other Plant-Derived Actives
The botanical oral care space includes several notable active ingredients. Understanding how α-mangostin compares helps position it effectively. Below is a comparison of α-mangostin with other plant-derived actives commonly used in oral care products.
A. α-Mangostin (Mangosteen Pericarp)
a. Primary Mechanism: Xanthone with antimicrobial, anti-inflammatory, and antibiofilm properties
b. Key Differentiator: Three mechanisms in one compound address infection, inflammation, and biofilm simultaneously
B. Tea Tree Oil (Melaleuca alternifolia)
a. Primary Mechanism: Terpene-based antimicrobial
b. Key Differentiator: Broad spectrum but weaker anti-inflammatory activity compared to α-mangostin
C. Neem (Azadirachta indica)
a. Primary Mechanism: Polyphenols and terpenoids
b. Key Differentiator: Strong anti-plaque effects but slower action; requires prolonged exposure for optimal results
D. Miswak (Salvadora persica)
a. Primary Mechanism: Alkaloids and flavonoids
b. Key Differentiator: Traditional use spanning centuries; combines mechanical cleaning with chemical activity
E. CBD (Cannabis sativa)
a. Primary Mechanism: Cannabinoid receptor modulation
b. Key Differentiator: Excellent anti-inflammatory properties but limited direct antimicrobial activity against oral pathogens
F. Spilanthol (Spilanthes acmella)
a. Primary Mechanism: Alkamide with analgesic properties
b. Key Differentiator: Provides pain relief and anti-inflammatory effects but offers less antimicrobial activity than α-mangostin
What Makes α-Mangostin Unique?
1. Dual Antimicrobial-anti-inflammatory Action
Unlike tea tree oil (primarily antimicrobial) or CBD (primarily anti-inflammatory), α-mangostin addresses both infectious and inflammatory components of periodontal disease simultaneously.
2. Potent Antibiofilm Activity
Biofilm formation is the root cause of most oral diseases. Many botanicals exhibit antimicrobial activity against planktonic (free-floating) bacteria but are ineffective against established biofilms. α-Mangostin has demonstrated clear antibiofilm effects against all three major oral pathogens.
3. Low Cytotoxicity
At therapeutic concentrations (≤29.2 µg/mL), α-mangostin shows no toxicity toward human gingival fibroblasts or oral keratinocytes. This safety profile is critical for daily-use oral care products.
4. Synergistic Compatibility
Research confirms α-mangostin works synergistically with other actives:
a. With lawsone methyl ether: Enhanced antimicrobial + antibiofilm
b. With fluoride: Increased enamel microhardness
c. With conventional antibiotics: Potential to reduce required dosages
What are the common FAQs?
Q1: Can α-mangostin be combined with fluoride?
A: Yes. Research has shown that tooth gels combining α-mangostin with lawsone methyl ether and fluoride demonstrated synergistic antimicrobial effects and increased enamel microhardness. However, compatibility testing is recommended for specific formulations.
Q2: Is α-mangostin safe for daily oral use?
A: Yes. A 180-day chronic toxicity study established a No-Observed-Effect Level (NOEL) of 0.16 g/kg body weight/day in rats, with a human equivalent dose of approximately 26 mg/kg body weight/day. This far exceeds typical daily exposure from oral care products. At therapeutic concentrations (≤29.2 µg/mL), α-mangostin shows no cytotoxicity to human gingival fibroblasts.
Q3: Does α-mangostin kill beneficial oral bacteria?
A: Current research focuses primarily on pathogenic strains such as S. mutans, P. gingivalis, and C. albicans. Unlike broad-spectrum synthetic antimicrobials, α-mangostin's mechanism may be more selective. However, further research is needed to fully characterise its effects on the commensal oral microbiome.
Q4: Does Mangosteen Extract contain any allergens?
A: Pure Mangosteen Extract derived from the pericarp is typically free from common allergens. However, cross-contamination may occur during processing. Request an allergen statement from your supplier confirming the absence of major allergens (soy, dairy, gluten, tree nuts, etc.).
Q5: How should Mangosteen Extract be stored for oral care manufacturing?
A: Store in sealed, airtight containers in a cool, dry place away from direct sunlight. Recommended conditions: temperature below 25°C (77°F) and relative humidity below 40%. Under these conditions, the product maintains stability for 24 months.
Q6: What is the typical price range for Mangosteen Extract?
A: Pricing varies significantly by purity: 1) 10% α-mangostin: Lower cost, suitable for daily products, 2) 40% α-mangostin: Variable cost, balanced performance, 3) 90%+ α-mangostin: Higher cost, used in therapeutic applications. Contact suppliers directly for current pricing based on volume and specifications.
Q7: Can I get samples before placing a bulk order?
A: Yes. Reputable suppliers, including Inhealth Nature, offer sample quantities for formulation testing and quality verification. Contact shaw@inhealthnature.com to request samples.
What sets α-mangostin from Mangosteen Extract Powder apart from other botanical actives is its trifecta of benefits: antimicrobial, antibiofilm, and anti-inflammatory, all within a single molecule, with a safety profile suitable for daily use. For oral care brands seeking to differentiate in a crowded market, α-mangostin offers a science-backed, consumer-friendly story: nature's solution for a healthier smile.
References
1. Antimicrobial and Anti-inflammatory Effects of α-Mangostin Soluble Film. J Int Soc Prev Community Dent. 2022;12(2):189–198.
2. Comparison between the efficacy of plant and synthetic origin dental products in the treatment of chronic catarrhal gingivitis. Kazan Medical Journal. 2020;101(1):25-30.
3. Oral spray containing plant-derived compounds is effective against common oral pathogens. Arch Oral Biol. 2018;90:80-85.
4. α-Mangostin and lawsone methyl ether in tooth gel synergistically increase its antimicrobial and antibiofilm formation effects. BMC Oral Health. 2023;23:840.
5. In Vitro Testing of Botanical Extracts as Safe and Effective Alternatives for Oral Care. Appl. Sci. 2025;16(5):2193.
